Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
A physiologically based pharmacokinetic (PBPK) model of selegiline (SEL), and its metabolites, was developed in silico to evaluate the disposition differences between healthy and special populations. SEL is metabolized to methamphetamine (MAP) and desmethyl selegiline (DMS) by several CYP enzymes. C...
Saved in:
Main Authors: | Santosh Kumar Puttrevu (Author), Sumit Arora (Author), Sebastian Polak (Author), Nikunj Kumar Patel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits
by: Ravi Kumar Jairam, et al.
Published: (2024) -
A physiologically‐based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites
by: Aparna Ramachandran, et al.
Published: (2023) -
Predicting Paclitaxel Disposition in Humans With Whole‐Body Physiologically‐Based Pharmacokinetic Modeling
by: Qiang Fu, et al.
Published: (2019) -
Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy
by: Ogochukwu U. Amaeze, et al.
Published: (2023) -
Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer's Disease: An Animal Model
by: Mudan Cai, et al.
Published: (2020)